|
Joyce, J N (2001) D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. Synapse 40:137-44
|
|
Gurevich, E V; Joyce, J N (2000) Dopamine D(3) receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat. J Comp Neurol 420:35-51
|
|
Gurevich, E V; Joyce, J N (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20:60-80
|
|
Joyce, J N; Gurevich, E V (1999) D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics. Ann N Y Acad Sci 877:595-613
|
|
Gurevich, E V; Himes, J W; Joyce, J N (1999) Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. J Pharmacol Exp Ther 289:587-98
|
|
Ryoo, H L; Pierrotti, D; Joyce, J N (1998) Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Mov Disord 13:788-97
|
|
Joyce, J N; Myers, A J; Gurevich, E (1998) Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Res 784:7-17
|
|
Joyce, J N; Murray, A M; Hurtig, H I et al. (1998) Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease. Neuropsychopharmacology 19:472-80
|
|
Thomas, W S; Neal-Beliveau, B S; Joyce, J N (1998) There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum. Brain Res Dev Brain Res 111:99-106
|
|
Joyce, J N; Smutzer, G; Whitty, C J et al. (1997) Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Mov Disord 12:885-97
|
Showing the most recent 10 out of 13 publications
